Serum Life Science Europe GmbH

Founded in August 2002, Serum Life Science Europe GmbH (SLS Europe) – formerly Vakzine Projekt Management GmbH (VPM) – was established following an initiative of the German Federal Ministry of Education and Research (BMBF) to promote vaccine development within the country. With a funding support from BMBF between 2001 and 2010, our company organized and financed the preclinical and clinical development of vaccines nationwide. Our efforts involved identifying promising vaccine candidates from public German laboratories and overseeing their development until they were licensed to industrial partners. To ensure a solid foundation for our mission, we crafted a comprehensive map of vaccine research with the associated technologies at the beginning of the BMBF funding and updated in 2006.